Valuation Novartis AG Mexican S.E.

Stocks

End-of-day quote Mexican S.E. Other stock markets 2026-07-07			5-day change	1st Jan Change
2,742.00 ^MXN	+0.62%		+0.62%	+9.68%

07-13	Novartis' Vanrafia Wins Health Canada Approval for IgA Nephropathy	MT
07-13	Wall Street's Stress Test Arrives

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	196,458	194,448	207,167	195,514	266,003	280,725	-	-
Change	-	-1.02%	6.54%	-5.62%	36.05%	5.53%	-	-
Enterprise Value (EV) ¹	204,649	203,482	219,178	213,458	289,870	312,751	309,262	303,575
Change	-	-0.57%	7.71%	-2.61%	35.8%	7.89%	-1.12%	-1.84%
P/E	8.2x	28.3x	14.1x	16.5x	19.2x	21.4x	18.1x	15.7x
PBR	2.9x	3.23x	4.41x	4.52x	5.73x	6.39x	5.99x	5.38x
PEG	-	-0.4x	0x	-1x	0.9x	-29.7x	1x	1x
Capitalization / Revenue	3.81x	3.85x	4.44x	3.78x	4.69x	4.94x	4.66x	4.39x
EV / Revenue	3.96x	4.03x	4.7x	4.13x	5.11x	5.5x	5.13x	4.74x
EV / EBITDA	11.2x	10.9x	12.2x	10.2x	12.4x	13.3x	12.2x	11x
EV / EBIT	12.3x	12.2x	13.4x	10.9x	13.2x	14.6x	13.3x	12x
EV / FCF	15.4x	17x	16.6x	13.1x	16.5x	23.2x	19.1x	16.3x
FCF Yield	6.49%	5.87%	6.01%	7.61%	6.07%	4.32%	5.24%	6.14%
Dividend per Share ²	3.36	3.5	3.823	3.856	-	4.402	4.548	4.785
Rate of return	3.83%	3.87%	3.79%	3.94%	-	2.87%	2.97%	3.12%
EPS ²	10.71	3.19	7.15	5.92	7.21	7.158	8.45	9.782
Distribution rate	31.4%	110%	53.5%	65.1%	-	61.5%	53.8%	48.9%
Net sales ¹	51,626	50,545	46,660	51,722	56,674	56,849	60,271	63,981
EBITDA ¹	18,246	18,613	17,937	21,006	23,415	23,501	25,357	27,529
EBIT ¹	16,588	16,665	16,372	19,494	21,889	21,491	23,278	25,234
Net income ¹	24,021	6,955	14,854	11,939	13,967	14,079	15,643	17,519
Net Debt ¹	8,191	9,034	12,011	17,944	23,867	32,026	28,537	22,850
Reference price ²	87.82	90.40	100.79	97.79	138.63	153.36	153.36	153.36
Nbr of stocks (in thousands)	2,237,092	2,150,980	2,055,460	1,999,270	1,918,792	1,830,549	-	-
Announcement Date	2/2/22	2/1/23	1/31/24	1/31/25	2/4/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	34.92x	12.63x	25.81x	0.57%	1,060B
JOHNSON & JOHNSON	27.42x	6.3x	17.1x	2.08%	619B
ABBVIE INC.	30.1x	7.34x	15.02x	2.76%	438B
ROCHE HOLDING AG	17.98x	4.45x	11.01x	2.97%	333B
ASTRAZENECA PLC	21.56x	4.53x	12.65x	1.94%	267B
NOVO NORDISK A/S	14.17x	5.3x	10.9x	3.52%	218B
AMGEN INC.	23.78x	6.31x	11.12x	2.78%	196B
GILEAD SCIENCES, INC.	-46.81x	5.6x	30.89x	2.5%	161B
PFIZER INC.	12.29x	3.03x	7.56x	7.14%	138B
Average	15.05x	6.16x	15.78x	2.92%	381.08B
Weighted average by Cap.	23.56x	7.84x	18.12x	2.13%